Elanco Animal Health Incorporated (ETR:5EA)

Market Cap	10.52B +77.9%
Revenue (ttm)	3.91B +3.1%
Net Income	30.68M -82.4%
EPS	0.06 -82.8%
Shares Out	n/a
PE Ratio	342.89
Forward PE	26.14
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	88
Open	21.36
Previous Close	21.72
Day's Range	21.36 - 21.36
52-Week Range	15.58 - 21.90
Beta	n/a
RSI	58.11
Earnings Date	Feb 24, 2026

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1954
• Employees: 9,450
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 5EA

Financial Performance

Financial numbers in USD